文献速递艾滋病与性传播感染

HIV病毒复制控制良好者贫血、中性粒细胞减少和血小板减少风险增加

Increased Risk of Anemia, Neutropenia, and Thrombocytopenia in People With Human Immunodeficiency Virus and Well-Controlled Viral Replication.
PubMed 文献 · J Infect Dis · 2019-01-01

本研究基于COCOMO研究纳入796例病毒复制检测不到且无慢性肝炎感染的HIV感染者,匹配2388例未感染对照,发现HIV感染者贫血、中性粒细胞减少和血小板减少患病率更高,且HIV是这些血细胞减少的独立危险因素,而淋巴细胞减少与HIV无关。

要点

  • 病毒控制良好的HIV感染者贫血、中性粒细胞减少和血小板减少风险仍显著高于未感染者。
  • HIV与中性粒细胞减少的关联最强(aOR 6.3),贫血和血小板减少的aOR分别为2.0和2.7。
  • 淋巴细胞减少与HIV无独立关联,需持续监测血细胞减少。

核心结论

  • 在病毒复制控制良好且无慢性肝炎感染的HIV感染者中,血细胞减少虽少见,但HIV仍是贫血、中性粒细胞减少和血小板减少的独立危险因素。

研究设计与样本

  • 从COCOMO研究招募796例病毒复制检测不到且无慢性肝炎感染的HIV感染者,从哥本哈根一般人群研究匹配2388例未感染对照,分析静脉血样本血细胞计数。

主要发现

  • HIV感染者贫血患病率6.9% vs 3.4%(P < .001),中性粒细胞减少1.3% vs 0.2%(P < .001),血小板减少5.5% vs 2.7%(P < .001)。
  • 调整年龄、性别、 ethnicity、吸烟、酒精和高敏C反应蛋白后,HIV与贫血独立相关(aOR 2.0,95% CI 1.4-3.0),与中性粒细胞减少独立相关(aOR 6.3,95% CI 2.0-19.6),与血小板减少独立相关(aOR 2.7,95% CI 1.8-4.2)。
  • HIV与淋巴细胞减少无关联。

临床怎么用

  • 对病毒控制良好的HIV感染者应持续关注并监测贫血、中性粒细胞减少和血小板减少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prior to the introduction of combination antiretroviral therapy (cART), cytopenias were common in people with human immunodeficiency virus (PWH), but it is unknown if well-controlled HIV infection is a risk factor for cytopenia. In this study we aimed to determine if HIV infection is an independent risk factor for anemia, neutropenia, lymphocytopenia, and thrombocytopenia. METHODS: PWH with undetectable viral replication and absence of chronic hepatitis infection (n = 796) were recruited from the Copenhagen Comorbidity in HIV Infection (COCOMO) study and matched uninfected controls from the Copenhagen General Population Study (n = 2388). Hematology was analyzed in venous blood samples. Logistic regression analyses adjusted for age, sex, ethnicity, smoking status, alcohol, and high-sensitivity C-reactive protein were performed to determine possible associations between HIV and cytopenias. RESULTS: PWH had a higher prevalence of anemia (6.9% vs 3.4%, P < .001), neutropenia (1.3% vs 0.2%, P < .001), and thrombocytopenia (5.5% vs 2.7%, P < .001) compared with uninfected controls. HIV was independently associated with anemia-adjusted odds ratio (aOR) of 2.0 (95% confidence interval [CI], 1.4-3.0); neutropenia aOR, 6.3 (95% CI, 2.0-19.6); and thrombocytopenia aOR, 2.7 (95% CI, 1.8-4.2). No association was found between HIV and lymphocytopenia. CONCLUSIONS: Cytopenia is rare in people with well-controlled HIV, but HIV remains a risk factor for anemia, neutropenia, and thrombocytopenia and requires ongoing attention and monitoring.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Akdag D, Knudsen AD, Thudium RF, et al. Increased Risk of Anemia, Neutropenia, and Thrombocytopenia in People With Human Immunodeficiency Virus and Well-Controlled Viral Replication. J Infect Dis. 2019. PMID: 31414119. doi:10.1093/infdis/jiz394

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。